-
Electronic (PDF)
-
Site License
-
Enterprisewide
Generic Pharmaceutical Manufacturing in the US
IBISWorld, October 2012, Pages: 50
The right dose: Emerging markets and the expiration of major patents will spur growth
Generic Pharmaceutical Manufacturing in the US
While this growing industry has been experiencing strong internal and external competition, the patent expirations of several brand-name drugs will create growth opportunities in the short term. Furthermore, healthcare reform will benefit the industry, with more consumers gaining insurance coverage for prescription drugs, improved generic drug approval processes and an established pathway to approval for biosimilars. As in the past five years, manufacturers will also pursue opportunities in biosimilars and emerging markets.
Generic pharmaceutical and medicine manufacturers develop prescription and over-the-counter drug products that are used to prevent or treat illnesses in humans or animals. Generic drugs are produced and distributed without patent protection, and industry operators are not significantly engaged in the research and development of new drugs. The industry does not include manufacturers of nutritional supplements or cosmetic beauty products.
This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.
ABOUT THIS INDUSTRY
Industry Definition
Main Activities
Similar Industries
Additional Resources
INDUSTRY AT A GLANCE
INDUSTRY PERFORMANCE
Executive Summary
Key External Drivers
Current Performance
Industry Outlook
Industry Life Cycle
PRODUCTS & MARKETS
Supply Chain
Products & Services
Demand Determinants
Major Markets
International Trade
Business Locations
COMPETITIVE LANDSCAPE
Market Share Concentration
Key Success Factors
Cost Structure Benchmarks
Basis of Competition
Barriers to Entry
Industry Globalization
MAJOR COMPANIES
OPERATING CONDITIONS
Capital Intensity
Technology & Systems
Revenue Volatility
Regulation & Policy
Industry Assistance
KEY STATISTICS
Industry Data
Annual Change
Key Ratios
JARGON & GLOSSARY
MAJOR COMPANIES.
Teva Pharmaceutical Industries Ltd.
Mylan Inc.
Sandoz Ltd.
Watson Pharmaceuticals, Inc.
Product Samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW4
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
